Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SWINE VACCINES INDUSTRY
2.1 Summary about Swine Vaccines Industry
2.2 Swine Vaccines Market Trends
2.2.1 Swine Vaccines Production & Consumption Trends
2.2.2 Swine Vaccines Demand Structure Trends
2.3 Swine Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 CSF Vaccines
4.2.2 FMD Vaccines
4.2.3 Porcine Circovirus Vaccines
4.2.4 PRRS Vaccines
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Government Tender
4.3.2 Market Sales
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 CSF Vaccines
5.2.2 FMD Vaccines
5.2.3 Porcine Circovirus Vaccines
5.2.4 PRRS Vaccines
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Government Tender
5.3.2 Market Sales
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 CSF Vaccines
6.2.2 FMD Vaccines
6.2.3 Porcine Circovirus Vaccines
6.2.4 PRRS Vaccines
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Government Tender
6.3.2 Market Sales
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 CSF Vaccines
7.2.2 FMD Vaccines
7.2.3 Porcine Circovirus Vaccines
7.2.4 PRRS Vaccines
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Government Tender
7.3.2 Market Sales
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 CSF Vaccines
8.2.2 FMD Vaccines
8.2.3 Porcine Circovirus Vaccines
8.2.4 PRRS Vaccines
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Government Tender
8.3.2 Market Sales
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 CSF Vaccines
9.2.2 FMD Vaccines
9.2.3 Porcine Circovirus Vaccines
9.2.4 PRRS Vaccines
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Government Tender
9.3.2 Market Sales
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck
10.1.2 Boehringer Ingelheim
10.1.3 Jinyu Bio-Technology
10.1.4 CAHIC
10.1.5 Tecon
10.1.6 Zoetis
10.1.7 Ceva
10.1.8 Hile Bio
10.1.9 Chopper Biology
10.1.10 WINSUN
10.1.11 Hipra
10.1.12 Ringpu Biology
10.1.13 ChengDu Tecbond
10.1.14 DHN
10.1.15 CAVAC
10.1.16 Virbac
10.1.17 HVRI
10.1.18 Bioveta
10.2 Swine Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 Merck
10.2.2 Boehringer Ingelheim
10.2.3 Jinyu Bio-Technology
10.2.4 CAHIC
10.2.5 Tecon
10.2.6 Zoetis
10.2.7 Ceva
10.2.8 Hile Bio
10.2.9 Chopper Biology
10.2.10 WINSUN
10.2.11 Hipra
10.2.12 Ringpu Biology
10.2.13 ChengDu Tecbond
10.2.14 DHN
10.2.15 CAVAC
10.2.16 Virbac
10.2.17 HVRI
10.2.18 Bioveta
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
